MET and thyroid gland carcinoma: Liu et al. found that lncXIST was upregulated in thyroid cancer tissues and cell lines and promoted the activation of the MET-PI3K-AKT signaling pathway through sponging miR-34a to promote the development of thyroid cancer [50].